=== PAGE 4 ===

COMPLETE PAGE ANALYSIS:
--------------------------------------------------
Johannes Czernin, MD                                                                                                                                                                    Page 4
UCLA
██████████████ (b) (4) /MA#1

The violations discussed in this letter do not necessarily constitute an exhaustive list. It is
your responsibility to ensure that your materials for Ga68-PSMA████ (b) (4) comply with each
applicable requirement of the FD&C Act and FDA implementing regulations.

                                                                                                                                                            Sincerely,

                                                                                                                                                            {See appended electronic signature page}
                                                                                                                                                            Zarna Patel, PharmD
                                                                                                                                                            Regulatory Review Officer
                                                                                                                                                            Division of Advertising & Promotion Review 2
                                                                                                                                                            Office of Prescription Drug Promotion

                                                                                                                                                            {See appended electronic signature page}
                                                                                                                                                            James Dvorsky, PharmD, RAC
                                                                                                                                                            Team Leader
                                                                                                                                                            Division of Advertising & Promotion Review 2
                                                                                                                                                            Office of Prescription Drug Promotion Division

Reference ID: 4201253
